Detalles de la búsqueda
1.
Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemia.
Leukemia
; 19(11): 1905-11, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16151467
2.
Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
Cancer Res
; 52(17): 4758-65, 1992 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-1380890
3.
Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
Oncogene
; 18(4): 967-78, 1999 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-10023672
4.
A rat monoclonal antibody which interacts with mammalian ornithine decarboxylase at an epitope involved in phosphorylation.
Biochim Biophys Acta
; 884(2): 370-82, 1986 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-2429708
5.
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.
J Clin Oncol
; 12(4): 730-9, 1994 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-8151316
6.
Tumor necrosis factor alpha: a multifaceted peptide hormone.
Crit Rev Immunol
; 9(1): 21-44, 1989.
Artículo
en Inglés
| MEDLINE | ID: mdl-2539946
7.
EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
Clin Cancer Res
; 6(1): 193-202, 2000 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-10656450
8.
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.
Clin Cancer Res
; 7(5): 1204-13, 2001 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11350885
9.
Activation of epidermal growth factor receptor tyrosine phosphorylation by tumor necrosis factor correlates with loss of cytotoxic activity.
J Interferon Cytokine Res
; 16(4): 307-14, 1996 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-9162524
10.
JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis.
J Interferon Cytokine Res
; 19(3): 261-9, 1999 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10213465
11.
Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.
J Interferon Cytokine Res
; 21(5): 313-22, 2001 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11429162
12.
Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID).
J Immunol Methods
; 85(2): 353-61, 1985 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-4078317
13.
Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A2 toxin. A novel growth inhibitory mechanism.
Biochem Pharmacol
; 51(11): 1535-43, 1996 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-8630095
14.
Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines.
Cancer Chemother Pharmacol
; 47(6): 473-80, 2001 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-11459199
15.
Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacement.
Int J Gynecol Cancer
; 10(2): 105-114, 2000 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11240661
16.
Growth state-dependent alterations in the ability of 12-O-tetradecanoylphorbol-13-acetate to increase ornithine decarboxylase activity in Reuber h35 Hepatoma cells.
Cancer Res
; 41(9 Pt 1): 3384-91, 1981 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-6266654
17.
p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells.
Leukemia
; 25(5): 761-9, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21350558
18.
Clinical use of tyrosine kinase inhibitors: therapy for chronic myelogenous leukemia and other cancers.
Clin Cancer Res
; 6(8): 2965-6, 2000 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10955770
19.
An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259.
Oncogene
; 27(56): 7055-69, 2008 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-18794796
20.
Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cells.
J Cell Biochem
; 98(2): 356-69, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16440323